Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
covid-19_therapeutics_task_force [2023/04/29 19:32]
liam [Members]
covid-19_therapeutics_task_force [2023/04/30 06:47] (current)
liam [History]
Line 3: Line 3:
 The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force)) The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force))
  
 +===== History =====
 +
 +[[Navdeep Bains]], Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.((Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). //Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies.// Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html)) Bains also announced the membership of the [[COVID-19 Vaccine Task Force]].
 ===== Members ===== ===== Members =====
  
Line 26: Line 29:
 | [[Don Sheppard]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4)  | | [[Don Sheppard]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4)  |
 | [[Don Vinh]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE)  | | [[Don Vinh]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE)  |
 +
 +===== External links =====
 +
 +  * [[http://covidtruthinitiative.ca/Organizations/COVID-19-Therapeutics-Task-Force|COVID Truth Initiative]]
Back to top